As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...